Tags

4 pages

Samsung Biologics

A Large Target-Price Gap Is Not Enough: KB Financial and Hana Financial Screen Best

Six Korean Bio Stocks, Made Simple — 'The Catalyst Is Alive' and 'It's Cheap' Are Not the Same Thing (2026-06-11)

The Samsung-Hynix Concentration Continues: 35 Quality Stocks to Revisit in Q3

Korean Biotech Sector Investment Thesis — Not a 'Buy Good Tech' Market. A 'Buy What the Market Has Underpriced' Market (2026-05-12)